Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities    
Net loss from continuing operations $ (2,292) $ (3,712)
Net loss from discontinued operations 0 (557)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Gain on sale of digital assets 0 (3,214)
Gain on extinguishment of debt (535) 0
Stock based compensation 630 1,362
Other adjustments 329 313
Changes in operating assets and liabilities:    
Accounts receivable (82) (284)
Prepaid expenses and other assets (11) (116)
Accounts payable and accrued expenses (2,893) (52)
Lease liability payments (185) (263)
Deferred revenue (286) (114)
Net cash used in operating activities from continued operations (5,325) (6,637)
Net cash used in operating activities from discontinued operations (205) (745)
Net cash used in operating activities (5,530) (7,382)
Investing activities    
Proceeds received from sale of digital currencies 0 10,790
Net cash provided by investing activities - continuing operations 0 10,790
Net cash used in investing activities - discontinued operation 0 (6)
Net cash provided by investing activities 0 10,784
Financing activities    
Payments on borrowings 0 (4,270)
Proceeds from sales of common stock 23,204 0
Proceeds from exercise of options to purchase common stock 0 58
Payments on common stock repurchases 0 (475)
Net cash provided by (used in) by financing activities 23,204 (4,687)
Effect of exchange rate on cash (41) 24
Net increase (decrease) in cash and cash equivalents 17,633 (1,261)
Cash at the beginning of the period 3,934 1,955
Cash and cash equivalents at the end of the period 21,567 694
Supplemental disclosure of cash flow information    
Interest paid 4 434
Income taxes paid 26 0
Supplemental disclosures of non-cash financing activities:    
Issuance of common stock upon conversion of the 2022 Promissory Note 4,505 0
Issuance of common stock for payment of bonuses and consulting fees $ 35 $ 347